Rhodes Jason P
Dyne Therapeutics, Inc. · Director
Rhodes Jason P is listed in filings as Director at Dyne Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 6, 2026, including sale activity. Recent filings connect the profile to Dyne Therapeutics, Inc. (DYN) and Generation Bio Co. (GBIO). The current snapshot covers public activity from Nov 18, 2024 to May 6, 2026. Reported amounts are shown as $793.0K to $313.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $793k43.6k shares | SellMay 6, 2026 | $18.18 | $22.72 | |
| $399k21.9k shares | SellMay 6, 2026 | $18.18 | $22.72 | |
| $313k17.2k shares | SellMay 6, 2026 | $18.18 | $22.72 | |
| $7.8k428 shares | SellMay 6, 2026 | $18.18 | $22.72 |